[1]
“Clinical spectrum of demyelinating disease of central nervous system and frequency of anti AQP4 and anti MOG among them: one-year single-center retrospective study”, J Ideas Health, vol. 7, no. 4, pp. 1100–1105, Aug. 2024, doi: 10.47108/jidhealth.Vol7.Iss4.353.